Food and Drug Regulations (C.R.C., c. 870)

Regulations are current to 2017-11-20 and last amended on 2017-11-13. Previous Versions

AMENDMENTS NOT IN FORCE

  • — 2014, c. 20, s. 366(3)

    • Replacement of “trade-mark” in regulations
      • 366 (3) Unless the context requires otherwise, “trade-mark”, “trade-marks”, “Trade-mark”, “Trade-marks”, “trade mark” and “trade marks”, are replaced by “trademark”, “trademarks”, “Trademark” or “Trademarks”, as the case may be, in the English version of any regulation, as defined in subsection 2(1) of the Statutory Instruments Act.

  • — SOR/2017-76, s. 7

    • 7 Subsection C.01A.001(2) of the Regulations is replaced by the following:

      • (2) In this Division and in Division 2, drug does not include any of the following:

        • (a) a dilute drug premix;

        • (b) a medicated feed as defined in subsection 2(1) of the Feeds Regulations, 1983;

        • (c) an active ingredient that is for veterinary use and that is not an active pharmaceutical ingredient;

        • (d) an active pharmaceutical ingredient for veterinary use that is not required to be sold pursuant to a prescription and that is also a natural health product as defined in subsection 1(1) of the Natural Health Products Regulations;

        • (e) a drug that is used only for the purposes of an experimental study in accordance with a certificate issued under section C.08.015.

  • — SOR/2017-76, s. 8(1)

      • (1) The portion of paragraph C.01A.002(1)(b) of the Regulations before subparagraph (i) is replaced by the following:

        • (b) subject to subsection (3), importing or compounding, pursuant to a prescription, a drug that is not commercially available in Canada by one of the following persons:

  • — SOR/2017-76, s. 8(3)

      • (3) Section C.01A.002 of the Regulations is amended by adding the following after subsection (2):

        • (3) This Division applies to the importing, by a pharmacist, a veterinary practitioner or a person who compounds a drug under the supervision of a veterinary practitioner, of an active pharmaceutical ingredient for veterinary use that is for the purpose of compounding, pursuant to a prescription, a drug in dosage form that is not commercially available in Canada, if that ingredient is set out in List A.

  • — SOR/2017-76, s. 9

    • 9 Table II to section C.01A.008 of the Regulations is amended by adding the following after item 6:

      TABLE II

      ItemCategories of Drugs
      7Active pharmaceutical ingredients set out in List A that are for veterinary use
Date modified: